Infiltrating ductal carcinoma (IDC) occurs frequently in patients with lobular carcinoma in-situ (LCIS). LCIS is not thought to be the direct precursor of the invasive component. The authors analyzed 15 cases of coexisting LCIS and IDC and found ductal carcinoma in situ (DCIS) in 12. The DCIS and IDC were of similar grade and located in the same area. Selected cases stained with E-cadherin demonstrated a different immunophenotype for the lobular and ductal lesions. These results support the notion that DCIS is the direct precursor of IDC occurring in patients with LCIS.
1. Lagios MD, Page DL. Chapter 12. In situ carcinomas of the breast: Ductal carcinoma in situ, Paget's disease, lobular carcinoma in situ. In Bland KI, Copeland EM III (eds): The breast. Comprehensive management of benign and malignant diseases, 2nd ed.WB Saunders, Philadelphia, pp. 277-280, 1998
2.
2. Morrow M, Schnitt SJ. Chapter 26. Lobular carcinoma in situ. In Harris JR, Lippman ME, Morrow M, Osborne CK (eds): Diseases of the breast, 2nd ed.Lippincott Williams & Wilkins, Philadelphia, pp. 377-381, 2000
3.
3. Rosen PP. Coexistent lobular carcinoma in situ and intraductal carcinoma in a single lobular-duct unit. Am J Surg Pathol4:241-246, 1980
4.
4. Ottensen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. Am J Surg Pathol16:1183-1196, 1992
5.
5. Ottensen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. Am J Surg Pathol17:14-21, 1993
6.
6. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, Wolmark N, Wickerham DL, Deutsch M, Ore L, Mamounas E, Poller W, Kavanah M.Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med328:158-186, 1993
7.
7. Moll R, Mitze M, Frixen UH, Birchmeier W.Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol143:1731-1742, 1993
8.
8. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology19:403-410, 1991
9.
9. Rosen PP. Chapter 35. Lobular carcinoma in situ and atypical lobular hyperplasia. In Rosen's breast pathology. Lippincott-Raven, Philadelphia, pp. 507-544, 1997
10.
10. Haagensen CD, Lane N, Bodian C.Coexisting lobular neoplasia and carcinoma of the breast. Cancer51:1468-1482, 1983
11.
11. Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, Wolmark N.Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer78:1403-1416, 1996
12.
12. Bodian CA, Perzin KH, Lattes R.Lobular neoplasia. Long-term risk of breast cancer and relation to other factors. Cancer78:1024-1034, 1996
13.
13. Nayar R, Zhuang Z, Merino M, Silverberg SG. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Hum Pathol28:277-282, 1997
14.
14. Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol150:297-303, 1997
15.
15. Visscher DW, Wallis TL, Crissman JD. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer77:315-320, 1996
16.
16. Berx G, Cleton-Jansen AM, Trumane K, de Leeuw WJF, Nollet F, van Roy F, Cornelisse CJ. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene13:1919-1925, 1996
17.
17. Huiping C, Sigurgeirsdottir JR, Jonasson JG, Eiriksdottir G, Johannsdottir JT, Egilsson V, Ingvarsson S.Chromosome alterations and E-cadherin gene mutations in human lobular cancer. Br J Cancer81:1103-1110, 1999
18.
18. Vos CBJ, Cleton-Jansen AM, Berx G, de Leeuw WJF, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ. E-cadherin inactivation in lobular carcinoma in situ of the breast: An early event in tumorigenesis. Br J Cancer76:1131-1133, 1997
19.
19. Kashiwaba M, Tamura G, Suzuki Y, Maesawa C, Ogasawara S, Sakata K, Satodate R.Epithelial-cadherin gene is not mutated in ductal carcinoma of the breast. Jpn J Cancer Res86:1054-1059, 1995
20.
20. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, Cano A.Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol142:987-993, 1993
21.
21. Rasbridge SA, Gillet CE, Sampson SA, Walsh FS, Millis RR. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol169:245-250, 1993
22.
22. Nemoto T, Castillo N, Tsukada Y, Koul A, Eckhert KH, Bauer RL. Lobular carcinoma in situ with microinvasion. J Surg Oncol67:41-46, 1998
23.
23. Lakhani SR, Collins N, Stratton MR. Loss of heterozygosity in lobular carcinoma in situ of the breast. J Clin Pathol Mol Pathol48:M74-M78, 1995
24.
24. Lishman SC, Lakhani SR. Atypical lobular hyperplasia and lobular carcinoma in situ: Surgical and molecular pathology. Histopathology35:195-200, 1999
25.
25. Page DL, Kidd TE, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast. Higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol22:1232-1239, 1991
26.
26. Green I, McCormick B, Cranor M, Rosen PP. A comparative study of pure tubular and tubulolobular carcinoma of the breast. Am J Surg Pathol21:653-657, 1997
27.
27. Fisher ER, Gregorio RM, Redmond C, Fisher B.Tubulolobular invasive breast cancer: A variant of lobular invasive cancer. Hum Pathol8:679-683, 1977
28.
28. Wheeler JE, Enterline HT. Lobular carcinoma of the breast in situ and infiltrative. In Sommers SC (ed): Pathology annual, Vol. 11, Appleton Century Crofts, New York, pp. 161-188, 1976
29.
29. Rosen PP, Lieberman PH, Braun DW, Kosloff C, Adair F.Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol2:225-251, 1978
30.
30. Salvadori B, Bartoli C, Zurrida S, Delledone V, Squicciarini P, Rovini D, Barletta L.Risk of invasive carcinoma in women with lobular carcinoma in situ of the breast. Eur J Cancer27:35-37, 1991
